XML 42 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income $ 86,628 $ 73,415
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Tax benefit from the exercise of options (4,298) (4,178)
Depreciation and amortization 9,104 7,849
Loss on disposal of fixed assets 175 609
Impairment of note receivable 6,955 0
Non-cash compensation 12,660 8,337
Provision for doubtful accounts and chargebacks 2,249 4,352
Accrued interest on note receivable – related party 529 (179)
Deferred rent expense 1,264 (556)
Realized loss (gain) on sale of marketable securities (2,029) (1,254)
Changes in:    
Accounts receivable 5,496 (40,030)
Due from factor (96,899) (53,184)
Inventories (22,180) (25,301)
Prepaid expenses, deposits and other assets (5,792) (2,329)
Accounts payable and other accrued expenses 20,896 39,834
Net cash provided by (used in) operating activities 14,758 7,385
Cash flows from investing activities:    
Purchases of property and equipment (15,617) (12,246)
Purchases of marketable securities (48,955) (13,983)
Purchase of note receivable (3,085) 0
Payment of contingent liability (7,076) 0
Sale of marketable securities 40,150 64,885
Acquisition, net of cash acquired (29,367) (85,234)
Net cash used in investing activities (63,950) (46,578)
Cash flows from financing activities:    
Proceeds from exercise of stock options 6,991 4,005
Tax benefit from the exercise of options 4,298 4,178
Net cash provided by financing activities 11,289 8,183
Net decrease in cash and cash equivalents (37,903) (31,010)
Cash and cash equivalents – beginning of period 102,830 66,151
Cash and cash equivalents – end of period $ 64,927 $ 35,141